Clinical Trial Update: Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion [Phase 2]

View source ↗

Summary

Phase 2 trial update on resveratrol's effects for metabolic syndrome, insulin sensitivity, and insulin secretion has completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Resveratrol (resveratrol)

Snippet

Sponsor: University of Guadalajara | Conditions: Metabolic Syndrome X | Phase 2 | Status: COMPLETED | Results posted: 2014-12-29